Skip to content
Oxycodone
Codoxy, Combunox, Oxaydo, Oxycontin, Percocet, Percodan, Percodan-demi, Roxicet, Roxicodone, Roxilox, Roxiprin, Roxybond, Targiniq, Troxyca, Tylox, Xartemis, Xtampza (oxycodone) is a small molecule pharmaceutical. Oxycodone was first approved as Oxycodone and acetaminophen on 1982-01-01. It is used to treat postoperative pain in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Oxaydo, Oxycontin, Roxicodone, Roxybond, Xtampza (generic drugs available since 1983-12-07)
Combinations
Percodan (generic drugs available since 1983-12-07, discontinued: Codoxy, Combunox, Percocet, Percodan, Percodan-demi, Roxicet, Roxilox, Roxiprin, Targiniq, Troxyca, Tylox, Xartemis)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acetaminophen
+
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
XARTEMIS XRMallinckrodtN-204031 DISCN2014-03-11
1 products, RLD
Hide discontinued
Aspirin
+
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
PERCODANEndoN-007337 RX2005-08-05
1 products, RLD, RS
Aspirin
+
Oxycodone hydrochloride
+
Oxycodone terephthalate
Tradename
Company
Number
Date
Products
PERCODAN-DEMIEndoN-007337 DISCN1982-01-01
1 products
PERCODANEndoN-007337 DISCN1982-01-01
1 products
Hide discontinued
Ibuprofen
+
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
COMBUNOXForest LaboratoriesN-021378 DISCN2004-11-26
1 products, RLD
Hide discontinued
Naloxone hydrochloride
+
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
TARGINIQPurdue PharmaN-205777 DISCN2014-07-23
3 products, RLD
Hide discontinued
Naltrexone hydrochloride
+
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
TROXYCA ERMylanN-207621 DISCN2016-08-19
6 products
Hide discontinued
Oxycodone
Tradename
Company
Number
Date
Products
XTAMPZA ERCollegium PharmaceuticalN-208090 RX2016-04-26
5 products, RLD, RS
Oxycodone hydrochloride
Tradename
Company
Number
Date
Products
OXYCODONE HYDROCHLORIDEGenus LifesciencesN-200534 RX2010-10-20
1 products, RLD, RS
OXYCODONE HYDROCHLORIDEGenus LifesciencesN-200535 RX2010-10-20
2 products, RLD, RS
ROXYBONDProtega PharmaceuticalsN-209777 RX2017-04-20
3 products
OXYCONTINPurdue PharmaN-022272 RX2010-04-05
7 products, RLD
ROXICODONESPECGXN-021011 RX2000-08-31
3 products, RLD
OXYCODONE HYDROCHLORIDEVistaPharmN-201194 RX2012-01-12
1 products, RLD, RS
OXAYDOZyla Life SciencesN-202080 RX2011-06-17
2 products, RLD
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
oxaydoNew Drug Application2021-03-31
oxycodone and acetaminophenANDA2023-05-24
oxycontinNew Drug Application2021-10-25
percocetANDA2022-11-22
roxicetANDA2016-08-12
roxicodoneNew Drug Application2021-03-09
roxybondNew Drug Application2022-03-31
targiniqNew Drug Application2016-12-22
xtampza New Drug Application2021-03-11
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
postoperative pain—D010149G89.18
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Oxycodone, Xtampza Er, Collegium Pharm Inc
97375302036-09-02DPU-1556
99685982036-09-02DPU-1556
101886442036-09-02DPU-1556
106464852036-09-02DPU-1556
96820752030-12-10DPU-1556
100047292030-12-10DPU-1556
106680602030-12-10DPU-1556
87588132025-06-10U-1556
73994882025-03-24DP
77717072025-03-24DP
84499092025-03-24DP
85572912025-03-21DP
88409282023-07-07DPU-1556
90443982023-07-07DP
92481952023-07-07U-1556
95922002023-07-07DP
97638832023-07-07DP
105250522023-07-07DPU-1556
105250532023-07-07DP
Acetaminophen / Oxycodone Hydrochloride, Xartemis Xr, Mallinckrodt Inc
86586312032-05-16DP
87418852032-05-16DPU-1499
89929752032-05-16DP
90503352032-05-16DP
94686362032-05-16U-1499
85976812030-12-21DP
89803192030-12-21DP
83774532029-11-19DPU-1499
83724322029-03-11DPU-1499
83944082029-03-11DP
86689292029-03-11U-1499
79768702027-06-01U-1498
Oxycodone Hydrochloride, Oxycontin, Purdue Pharma Lp
88949872030-03-29DP
88087412027-08-24U-1556
88949882027-08-24DP
94923892027-08-24DP
94923912027-08-24U-1556
94923922027-08-24DP
94923932027-08-24U-1556
97639332027-08-24DP
97704162027-08-24DP
97758082027-08-24DP
113049082027-08-24DP
113049092027-08-24U-1556
104074342025-03-30DP
106966842025-03-30DP
83090602023-11-20DPU-1556
101305912023-11-20DPU-1819
106752782023-11-20DP
96756102023-06-16DP
103691092023-06-16DP
Oxycodone Hydrochloride, Roxybond, Protega Pharms
79556192028-08-12DP
103147882028-08-12DP
Naltrexone Hydrochloride / Oxycodone Hydrochloride, Troxyca Er, Pfizer
78159342027-12-12DP
86854432025-07-03U-1508
Naloxone Hydrochloride / Oxycodone Hydrochloride, Targiniq, Purdue Pharma Lp
90739332025-03-30DP
95229192025-03-30DS, DP
88460902023-04-04DP
88460912023-04-04DP
95550002023-04-04DPU-1556
99077932023-04-04DPU-1556
Oxycodone Hydrochloride, Oxaydo, Zyla
72019202025-03-16DP
94924432024-05-26DP
75107262023-11-26DP
79814392023-11-26DP
84096162023-11-26DP
86375402023-11-26DP
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AA: Natural opium alkaloid analgesics
— N02AA05: Oxycodone
— N02AA55: Oxycodone and naloxone
— N02AA56: Oxycodone and naltrexone
— N02AJ: Opioids in combination with non-opioid analgesics
— N02AJ17: Oxycodone and paracetamol
— N02AJ18: Oxycodone and acetylsalicylic acid
— N02AJ19: Oxycodone and ibuprofen
HCPCS
No data
Clinical
Clinical Trials
433 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52972918871
Postoperative painD010149G89.18262132970
Healthy volunteers/patients—34——2137
Opioid-related disordersD009293EFO_0005611F1174—4318
NeoplasmsD009369C80—346417
Low back painD017116HP_0003419M54.51—104116
Chronic painD059350HP_00125325—27115
Acute painD059787R5241—4312
OsteoarthritisD010003EFO_0002506M15-M191342111
Cancer painD000072716G89.3—22329
Show 72 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Knee osteoarthritisD020370EFO_0004616M17—34—18
Head and neck neoplasmsD0062582—1—14
AnesthesiaD000758—11—34
ArthralgiaD018771HP_0002829M25.5—12——3
Hip osteoarthritisD015207EFO_1000786M16——2——2
Anterior cruciate ligament injuriesD000070598—12——2
Joint diseasesD007592HP_0003040M12.9——2——2
Parkinson diseaseD010300EFO_0002508G20—12——2
Diabetic neuropathiesD003929EFO_1000783—11——2
LymphomaD008223C85.9——1—12
Show 20 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental pinsD003772—1———1
Rotator cuff injuriesD000070636M75.1—1———1
TonsillectomyD014068—1———1
ToothacheD014098K08.89—1———1
Interstitial cystitisD018856EFO_1000869N30.1—1———1
Pre-eclampsiaD011225EFO_0000668O14—1———1
Spinal cord injuriesD013119EFO_1001919—1———1
Multiple traumaD009104T07—1———1
Abdominal herniaD046449K46—1———1
Wounds and injuriesD014947T14.8—1———1
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnalgesiaD0006982———13
HypercapniaD0069352————2
StomatitisD013280EFO_1001904K12.12————2
Drug interactionsD0043471———12
Recreational drug useD0000847832————2
Colorectal neoplasmsD0151791————1
Replacement arthroplasty kneeD0196451————1
Urologic diseasesD014570N39.91————1
Squamous cell carcinoma of head and neckD0000771951————1
ArthrodesisD0011741————1
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.9————11
Hip fracturesD006620EFO_0003964S72.00————11
ObesityD009765EFO_0001073E66.9————11
Peripheral arterial diseaseD058729EFO_0004265————11
Forearm injuriesD005543S59.91————11
Squamous cell carcinomaD002294————11
Herpes zosterD006562EFO_0006510B02————11
Nasopharyngeal neoplasmsD009303————11
Liver cirrhosisD008103EFO_0001422K74.0————11
Alpha 1-antitrypsin deficiencyD019896E88.01————11
Show 15 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXYCODONE
INNoxycodone
Description
Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive. It is an organic heteropentacyclic compound and a semisynthetic derivative. It is functionally related to a thebaine. It is a conjugate base of an oxycodone(1+). It derives from a hydride of a morphinan.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314
Identifiers
PDB—
CAS-ID76-42-6
RxCUI7804
ChEMBL IDCHEMBL656
ChEBI ID7852
PubChem CID5284603
DrugBankDB00497
UNII IDCD35PMG570 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Xtampza - Collegium Pharmaceutical
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Oxaydo - Assertio Therapeutics
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Oxaydo - Zyla Life Sciences
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 17,391 documents
View more details
Safety
Black-box Warning
Black-box warning for: Oxaydo, Oxycodone and acetaminophen, Oxycontin, Percocet, Roxicodone, Roxybond, Targiniq, Xtampza
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details